69 related articles for article (PubMed ID: 22634534)
1. Recent advances in testicular germ cell tumours.
Mele T; Reid A; Huddart R
Fac Rev; 2021; 10():67. PubMed ID: 34557871
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives.
Lobo J; Jerónimo C; Henrique R
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560427
[TBL] [Abstract][Full Text] [Related]
3. Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors.
Bakardjieva-Mihaylova V; Skvarova Kramarzova K; Slamova M; Svaton M; Rejlova K; Zaliova M; Dobiasova A; Fiser K; Stuchly J; Grega M; Rosova B; Zachoval R; Klezl P; Eis V; Kindlova E; Buchler T; Trka J; Boublikova L
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31500094
[TBL] [Abstract][Full Text] [Related]
4. The genomic landscape of testicular germ cell tumours: from susceptibility to treatment.
Litchfield K; Levy M; Huddart RA; Shipley J; Turnbull C
Nat Rev Urol; 2016 Jul; 13(7):409-19. PubMed ID: 27296647
[TBL] [Abstract][Full Text] [Related]
5. Association of metallothionein expression and clinical response to cisplatin based chemotherapy in testicular germ cell tumors.
Tuzel E; Yorukoglu K; Ozkara E; Kirkali Z
Cent European J Urol; 2015; 68(1):45-50. PubMed ID: 25914837
[TBL] [Abstract][Full Text] [Related]
6. SKI-II reverses the chemoresistance of SGC7901/DDP gastric cancer cells.
Liu Y; Zhu Z; Cai H; Liu Q; Zhou H; Zhu Z
Oncol Lett; 2014 Jul; 8(1):367-373. PubMed ID: 24959278
[TBL] [Abstract][Full Text] [Related]
7. Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin.
Grande L; Bretones G; Rosa-Garrido M; Garrido-Martin EM; Hernandez T; Fraile S; Botella L; de Alava E; Vidal A; Garcia del Muro X; Villanueva A; Delgado MD; Fernandez-Luna JL
J Biol Chem; 2012 Aug; 287(32):26495-505. PubMed ID: 22718761
[TBL] [Abstract][Full Text] [Related]
8. The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?
Ottaviano M; Giunta EF; Rescigno P; Pereira Mestre R; Marandino L; Tortora M; Riccio V; Parola S; Casula M; Paliogiannis P; Cossu A; Vogl UM; Bosso D; Rosanova M; Mazzola B; Daniele B; Palmieri G; Palmieri G
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281219
[TBL] [Abstract][Full Text] [Related]
9. Biological markers of cisplatin resistance in advanced testicular germ cell tumours.
García-Velasco A; Durán I; García E; Tarón M; Ballestín C; Castellanos D; Cortés-Funés H; Paz-Ares L
Clin Transl Oncol; 2012 Jun; 14(6):452-7. PubMed ID: 22634534
[TBL] [Abstract][Full Text] [Related]
10. p53 and MDM2 expression in primary and metastatic testicular germ cell tumors: Association with clinical outcome.
Lobo J; Alzamora MA; Guimarães R; Cantante M; Lopes P; Braga I; Maurício J; Jerónimo C; Henrique R
Andrology; 2020 Sep; 8(5):1233-1242. PubMed ID: 32384200
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
[TBL] [Abstract][Full Text] [Related]
12. Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review.
Romano FJ; Rossetti S; Conteduca V; Schepisi G; Cavaliere C; Di Franco R; La Mantia E; Castaldo L; Nocerino F; Ametrano G; Cappuccio F; Malzone G; Montanari M; Vanacore D; Quagliariello V; Piscitelli R; Pepe MF; Berretta M; D'Aniello C; Perdonà S; Muto P; Botti G; Ciliberto G; Veneziani BM; De Falco F; Maiolino P; Caraglia M; Montella M; De Giorgi U; Facchini G
Oncotarget; 2016 Dec; 7(51):85641-85649. PubMed ID: 27821802
[TBL] [Abstract][Full Text] [Related]
13. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
